应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RNA Avidity Biosciences, Inc.
交易中 04-16 15:41:26 EDT
25.55
-1.13
-4.25%
最高
26.80
最低
25.28
成交量
68.84万
今开
26.38
昨收
26.68
日振幅
5.68%
总市值
30.71亿
流通市值
23.68亿
总股本
1.20亿
成交额
1,780万
换手率
0.74%
流通股本
9,270万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Avidity Biosciences, Inc.盘中异动 下午盘大幅跳水5.02%
市场透视 · 45分钟前
Avidity Biosciences, Inc.盘中异动 下午盘大幅跳水5.02%
Wave Life Sciences Ltd.盘中异动 股价大跌5.25%
市场透视 · 16:53
Wave Life Sciences Ltd.盘中异动 股价大跌5.25%
Applied Dna Sciences, Inc.盘中异动 早盘股价大跌5.03%报0.870美元
市场透视 · 04-15 14:28
Applied Dna Sciences, Inc.盘中异动 早盘股价大跌5.03%报0.870美元
新化合物能修复RNA异常 有助开发罕见病新疗法
金融界 · 04-15 02:22
新化合物能修复RNA异常 有助开发罕见病新疗法
Wave Life Sciences Ltd.盘中异动 早盘急速拉升5.04%报5.94美元
市场透视 · 04-14 14:15
Wave Life Sciences Ltd.盘中异动 早盘急速拉升5.04%报5.94美元
Applied Dna Sciences, Inc.股价重挫19.99% 市值跌20.31万美元
市场透视 · 04-14 13:31
Applied Dna Sciences, Inc.股价重挫19.99% 市值跌20.31万美元
Avidity Biosciences, Inc.盘中异动 股价大涨5.00%报25.32美元
市场透视 · 04-11
Avidity Biosciences, Inc.盘中异动 股价大涨5.00%报25.32美元
B of A Securities:维持Avidity Biosciences(RNA.US)评级,由买入调整至买入评级, 目标价由51.00美元调整至48.00美元。
金融界 · 03-10
B of A Securities:维持Avidity Biosciences(RNA.US)评级,由买入调整至买入评级, 目标价由51.00美元调整至48.00美元。
Wave Life Sciences Ltd.盘中异动 早盘股价大跌5.00%
市场透视 · 03-10
Wave Life Sciences Ltd.盘中异动 早盘股价大跌5.00%
Applied Dna Sciences, Inc.盘中异动 急速拉升5.78%
市场透视 · 03-10
Applied Dna Sciences, Inc.盘中异动 急速拉升5.78%
Avidity Biosciences, Inc.2024财年实现净利润-3.22亿美元,同比减少51.89%
市场透视 · 03-08
Avidity Biosciences, Inc.2024财年实现净利润-3.22亿美元,同比减少51.89%
Avidity Biosciences(RNA.US)获Scotiabank首次覆盖,给予跑赢大盘评级, 目标价70.00美元。
金融界 · 03-07
Avidity Biosciences(RNA.US)获Scotiabank首次覆盖,给予跑赢大盘评级, 目标价70.00美元。
Wave Life Sciences Ltd.盘中异动 股价大跌5.08%报10.66美元
市场透视 · 03-05
Wave Life Sciences Ltd.盘中异动 股价大跌5.08%报10.66美元
Applied Dna Sciences, Inc.盘中异动 大幅跳水6.27%
市场透视 · 03-04
Applied Dna Sciences, Inc.盘中异动 大幅跳水6.27%
Wave Life Sciences Ltd.盘中异动 下午盘快速下跌5.01%报10.04美元
市场透视 · 03-03
Wave Life Sciences Ltd.盘中异动 下午盘快速下跌5.01%报10.04美元
Avidity Biosciences, Inc.盘中异动 下午盘大幅下挫5.03%报29.10美元
市场透视 · 03-03
Avidity Biosciences, Inc.盘中异动 下午盘大幅下挫5.03%报29.10美元
巴克莱:维持Avidity Biosciences(RNA.US)评级,由增持调整至增持评级, 目标价由63.00美元调整至57.00美元。
金融界 · 02-28
巴克莱:维持Avidity Biosciences(RNA.US)评级,由增持调整至增持评级, 目标价由63.00美元调整至57.00美元。
Avidity Biosciences, Inc.盘中异动 股价大涨5.19%报30.59美元
市场透视 · 02-28
Avidity Biosciences, Inc.盘中异动 股价大涨5.19%报30.59美元
Avidity Biosciences(RNA.US):2024年Q4财报实现营收297.3万美元,前值为219.3万美元,预期值为162万美元;每股收益为-0.80美元,前值为-0.79美元,预期值为-0.78美元。
金融界 · 02-27
Avidity Biosciences(RNA.US):2024年Q4财报实现营收297.3万美元,前值为219.3万美元,预期值为162万美元;每股收益为-0.80美元,前值为-0.79美元,预期值为-0.78美元。
Wave Life Sciences Ltd.盘中异动 股价大涨5.21%报10.90美元
市场透视 · 02-26
Wave Life Sciences Ltd.盘中异动 股价大涨5.21%报10.90美元
加载更多
公司概况
公司名称:
Avidity Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Avidity Biosciences, Inc.是根据特拉华州法律于2012年11月13日成立的。该公司是一家生物制药公司。公司开创了一种新型的基于寡核苷酸的疗法,称为抗体寡核苷酸缀合物(AOC),旨在克服寡核苷酸疗法的当前局限性,以治疗多种严重的疾病。该公司利用其专有的AOC平台来设计,策划和开发结合单克隆抗体(mAbs)的组织选择性和寡核苷酸疗法的精确性的疗法,以访问以前无法吸收的组织和细胞类型,并更有效地针对疾病的潜在遗传驱动因素。
发行价格:
--
{"stockData":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":25.545,"timestamp":1744832485908,"preClose":26.68,"halted":0,"volume":688402,"delay":0,"floatShares":92698253,"shares":120212301,"eps":-2.888476,"marketStatus":"交易中","change":-1.135,"latestTime":"04-16 15:41:26 EDT","open":26.375,"high":26.795,"low":25.28,"amount":17798956.570538,"amplitude":0.056784,"askPrice":25.58,"askSize":115,"bidPrice":25.51,"bidSize":259,"shortable":3,"etf":0,"ttmEps":-2.888476,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1744833600000},"marketStatusCode":2,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":26.68,"preHourTrading":{"tag":"盘前","latestPrice":25,"preClose":26.68,"latestTime":"09:20 EDT","volume":329,"amount":8573.470549,"timestamp":1744809633466},"postHourTrading":{"tag":"盘后","latestPrice":26.68,"preClose":26.68,"latestTime":"17:07 EDT","volume":161236,"amount":4301776.48,"timestamp":1744751264537},"volumeRatio":0.363734,"impliedVol":0.8127,"impliedVolPercentile":0.8167},"requestUrl":"/m/hq/s/RNA","defaultTab":"news","newsList":[{"id":"2528546271","title":"Avidity Biosciences, Inc.盘中异动 下午盘大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528546271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528546271?lang=zh_cn&edition=full","pubTime":"2025-04-17 02:56","pubTimestamp":1744829819,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日02时56分,Avidity Biosciences, Inc.股票出现异动,股价快速跳水5.02%。Avidity Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.62%。Avidity Biosciences, Inc.公司简介:Avidity Biosciences Inc 是一家生物制药公司,致力于提供一类称为抗体寡核苷酸偶联物 的新型 RNA 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025659aa2c721d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025659aa2c721d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4505","BK4588","RNA"],"gpt_icon":0},{"id":"2528278582","title":"Wave Life Sciences Ltd.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528278582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528278582?lang=zh_cn&edition=full","pubTime":"2025-04-17 00:53","pubTimestamp":1744822394,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时53分,Wave Life Sciences Ltd.股票出现波动,股价快速跳水5.25%。截至发稿,该股报5.95美元/股,成交量25.6114万股,换手率0.17%,振幅3.74%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体跌幅为1.20%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417005314973a278e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417005314973a278e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4139","RNA","BK4585","WVE","BK4505"],"gpt_icon":0},{"id":"2527445489","title":"Applied Dna Sciences, Inc.盘中异动 早盘股价大跌5.03%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527445489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527445489?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:28","pubTimestamp":1744727300,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时28分,Applied Dna Sciences, Inc.股票出现异动,股价快速下跌5.03%。Applied Dna Sciences, Inc.股票所在的生命科学行业中,整体跌幅为0.87%。其相关个股中,Inotiv, Inc.、Endra Life Sciences Inc.、燃石医学涨幅较大,Applied Dna Sciences, Inc.、Endra Life Sciences Inc.、安奈特保险较为活跃,换手率分别为31.32%、2.37%、1.28%,振幅较大的相关个股有燃石医学、Inotiv, Inc.、Grail, Inc.,振幅分别为19.53%、10.97%、7.73%。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152228209738b4e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152228209738b4e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RNA","BK4109","BK4139","BK4585","BK4583","BK4588","APDN","DNA","BK4505"],"gpt_icon":0},{"id":"2527646101","title":"新化合物能修复RNA异常 有助开发罕见病新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2527646101","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527646101?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:22","pubTimestamp":1744683768,"startTime":"0","endTime":"0","summary":"日本京都大学等机构研究人员在新一期美国《科学进展》杂志上发表论文说,他们研发出一种低分子化合物,口服后能修复RNA(核糖核酸)错误剪接,从而为治疗法布雷病等基因突变引发的罕见遗传病提供新思路。研究人员说,这一成果不只是局限于法布雷病,也有可能应用于RNA错误剪接所导致的其他遗传病。这种化合物可以口服并有效地递送到心脏组织,有望在症状出现前预防性治疗相关疾病。\n\n\r\n 责任编辑:栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/04/15102249541147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4588","BK4139","BK4585","RNA","BK4505"],"gpt_icon":0},{"id":"2527194409","title":"Wave Life Sciences Ltd.盘中异动 早盘急速拉升5.04%报5.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527194409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527194409?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:15","pubTimestamp":1744640112,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时15分,Wave Life Sciences Ltd.股票出现波动,股价大幅拉升5.04%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体涨幅为1.31%。其相关个股中,Theratechnologies Inc.、Third Harmonic Bio, Inc.、Metsera, Inc.涨幅较大,Artelo Biosciences, Inc.、Aditxt, Inc.、Processa Pharmaceuticals, Inc.较为活跃,换手率分别为553.97%、308.02%、145.25%,振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Metsera, Inc.,振幅分别为48.67%、29.90%、23.79%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221512aa2c6e84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221512aa2c6e84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RNA","BK4505","BK4585","WVE","BK4588"],"gpt_icon":0},{"id":"2527164889","title":"Applied Dna Sciences, Inc.股价重挫19.99% 市值跌20.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527164889?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637518,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分,Applied Dna Sciences, Inc.股票出现波动,股价快速跳水19.99%。Applied Dna Sciences, Inc.股票所在的生命科学行业中,整体涨幅为0.98%。Applied Dna Sciences, Inc.公司简介:Applied DNA Sciences Inc 是一家开发和商业化生产和检测脱氧核糖核酸和核糖核酸技术的生物技术公司。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213158a6ba1c22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213158a6ba1c22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNA","RNA","BK4588","BK4121","APDN","BK4109","BK4585","BK4583","BK4505","BK4139"],"gpt_icon":1},{"id":"2526361377","title":"Avidity Biosciences, Inc.盘中异动 股价大涨5.00%报25.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526361377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2526361377?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:49","pubTimestamp":1744390144,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时49分,Avidity Biosciences, Inc.股票出现异动,股价大幅拉升5.00%。Avidity Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.57%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为2096.48%、1438.04%、385.38%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.,振幅分别为193.75%、156.27%、77.44%。Avidity Biosciences, Inc.公司简介:Avidity Biosciences Inc 是一家生物制药公司,致力于提供一类称为抗体寡核苷酸偶联物 的新型 RNA 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412004905a6b7fd66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412004905a6b7fd66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNA","BK4588","BK4585","BK4505","BK4139"],"gpt_icon":0},{"id":"2518208788","title":"B of A Securities:维持Avidity Biosciences(RNA.US)评级,由买入调整至买入评级, 目标价由51.00美元调整至48.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208788","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518208788?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Avidity Biosciences(RNA.US)评级,由买入调整至买入评级, 目标价由51.00美元调整至48.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RNA"],"gpt_icon":0},{"id":"2518779220","title":"Wave Life Sciences Ltd.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518779220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518779220?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:48","pubTimestamp":1741614536,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时48分,Wave Life Sciences Ltd.股票出现异动,股价大幅跳水5.00%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2691.51%、610.55%、93.48%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021485698a2a1a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021485698a2a1a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WVE","BK4505","RNA","BK4139","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2518274848","title":"Applied Dna Sciences, Inc.盘中异动 急速拉升5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518274848?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分,Applied Dna Sciences, Inc.股票出现异动,股价大幅拉升5.78%。Applied Dna Sciences, Inc.股票所在的生命科学行业中,整体跌幅为0.39%。Applied Dna Sciences, Inc.公司简介:Applied DNA Sciences Inc 是一家开发和商业化生产和检测脱氧核糖核酸和核糖核酸技术的生物技术公司。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021392898a29eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021392898a29eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNA","BK4505","BK4583","DNA","BK4121","BK4585","BK4588","APDN","BK4139","BK4109"],"gpt_icon":0},{"id":"2518812428","title":"Avidity Biosciences, Inc.2024财年实现净利润-3.22亿美元,同比减少51.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518812428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518812428?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449622,"startTime":"0","endTime":"0","summary":"3月9日,Avidity Biosciences, Inc.公布财报,公告显示公司2024财年净利润为-3.22亿美元,同比减少51.89%;其中营业收入为10.90百万美元,同比增加14.02%,每股基本收益为-2.89美元。从资产负债表来看,Avidity Biosciences, Inc.总负债1.39亿美元,其中短期债务3.84百万美元,资产负债比为11.26,流动比率为0.16。机构评级:截至2025年3月9日,当前有11家机构对Avidity Biosciences, Inc.目标价做出预测,其中目标均价为68.09美元,其中最低目标价为57.00美元,最高目标价为96.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000037abef96ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000037abef96ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNA"],"gpt_icon":0},{"id":"2517467349","title":"Avidity Biosciences(RNA.US)获Scotiabank首次覆盖,给予跑赢大盘评级, 目标价70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517467349","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517467349?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386747,"startTime":"0","endTime":"0","summary":"Avidity Biosciences(RNA.US)获Scotiabank首次覆盖,给予跑赢大盘评级, 目标价70.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08063248605337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RNA"],"gpt_icon":0},{"id":"2517944311","title":"Wave Life Sciences Ltd.盘中异动 股价大跌5.08%报10.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517944311?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:46","pubTimestamp":1741193179,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时46分,Wave Life Sciences Ltd.股票出现波动,股价急速跳水5.08%。截至发稿,该股报10.66美元/股,成交量34.3525万股,换手率0.22%,振幅6.50%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体涨幅为0.99%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。RNA药物平台PRISMTM结合多种模式、化学创新和对人类遗传学的深刻见解,提供治疗罕见和流行疾病的科学突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004620989d64bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004620989d64bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WVE","RNA","BK4505","BK4585","BK4007","BK4588","BK4139"],"gpt_icon":0},{"id":"2516067008","title":"Applied Dna Sciences, Inc.盘中异动 大幅跳水6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516067008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516067008?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:48","pubTimestamp":1741099724,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时48分,Applied Dna Sciences, Inc.股票出现异动,股价急速跳水6.27%。Applied Dna Sciences, Inc.股票所在的生命科学行业中,整体跌幅为0.75%。Applied Dna Sciences, Inc.公司简介:Applied DNA Sciences Inc 是一家开发和商业化生产和检测脱氧核糖核酸和核糖核酸技术的生物技术公司。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224844abe7f543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224844abe7f543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4588","BK4585","RNA","APDN","BK4505","BDSX","BK4121","DNA","BK4109","BK4196","BK4139"],"gpt_icon":0},{"id":"2516961663","title":"Wave Life Sciences Ltd.盘中异动 下午盘快速下跌5.01%报10.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516961663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516961663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:24","pubTimestamp":1741033496,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时24分,Wave Life Sciences Ltd.股票出现波动,股价急速跳水5.01%。截至发稿,该股报10.04美元/股,成交量41.9189万股,换手率0.27%,振幅5.71%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体涨幅为0.07%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。RNA药物平台PRISMTM结合多种模式、化学创新和对人类遗传学的深刻见解,提供治疗罕见和流行疾病的科学突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040424579637fb1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040424579637fb1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNA","BK4139","BK4505","BK4588","BK4585","WVE","BK4007"],"gpt_icon":0},{"id":"2516781668","title":"Avidity Biosciences, Inc.盘中异动 下午盘大幅下挫5.03%报29.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516781668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516781668?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:07","pubTimestamp":1741032465,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时07分,Avidity Biosciences, Inc.股票出现异动,股价急速下挫5.03%。Avidity Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大,Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为4585.87%、212.44%、182.79%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。Avidity Biosciences, Inc.公司简介:Avidity Biosciences Inc 是一家生物技术公司。其产品 AOC 1001 旨在治疗一种罕见的单基因肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040745989a5a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040745989a5a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","BK4588","BK4139","RNA"],"gpt_icon":0},{"id":"2516968307","title":"巴克莱:维持Avidity Biosciences(RNA.US)评级,由增持调整至增持评级, 目标价由63.00美元调整至57.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516968307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516968307?lang=zh_cn&edition=full","pubTime":"2025-03-01 06:11","pubTimestamp":1740780665,"startTime":"0","endTime":"0","summary":"巴克莱:维持Avidity Biosciences(RNA.US)评级,由增持调整至增持评级, 目标价由63.00美元调整至57.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01061148470375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RNA"],"gpt_icon":0},{"id":"2516301697","title":"Avidity Biosciences, Inc.盘中异动 股价大涨5.19%报30.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516301697?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:55","pubTimestamp":1740776151,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时55分,Avidity Biosciences, Inc.股票出现波动,股价急速拉升5.19%。Avidity Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3290.70%、614.33%、404.13%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ,振幅分别为57.80%、49.90%、48.19%。Avidity Biosciences, Inc.公司简介:Avidity Biosciences Inc 是一家生物技术公司。其产品 AOC 1001 旨在治疗一种罕见的单基因肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045552a258566c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045552a258566c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNA","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"2514354323","title":"Avidity Biosciences(RNA.US):2024年Q4财报实现营收297.3万美元,前值为219.3万美元,预期值为162万美元;每股收益为-0.80美元,前值为-0.79美元,预期值为-0.78美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354323","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514354323?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697728,"startTime":"0","endTime":"0","summary":"Avidity Biosciences(RNA.US):2024年Q4财报实现营收297.3万美元,前值为219.3万美元,预期值为162万美元;每股收益为-0.80美元,前值为-0.79美元,预期值为-0.78美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RNA"],"gpt_icon":0},{"id":"2514854801","title":"Wave Life Sciences Ltd.盘中异动 股价大涨5.21%报10.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514854801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514854801?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:12","pubTimestamp":1740582748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时12分,Wave Life Sciences Ltd.股票出现异动,股价快速拉升5.21%。截至发稿,该股报10.90美元/股,成交量12.1328万股,换手率0.08%,振幅4.25%。Wave Life Sciences Ltd.股票所在的生物技术行业中,整体跌幅为0.03%。Wave Life Sciences Ltd.公司简介:WAVE Life Sciences Ltd正在释放RNA药物的广泛潜力,也被称为寡核苷酸,它以核糖核酸为目标,改变人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623122896315793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623122896315793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","BK4007","WVE","BK4588","RNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aviditybiosciences.com","stockEarnings":[{"period":"1week","weight":0.108},{"period":"1month","weight":-0.1424},{"period":"3month","weight":-0.0427},{"period":"6month","weight":-0.4501},{"period":"1year","weight":0.1159},{"period":"ytd","weight":-0.0825}],"compareEarnings":[{"period":"1week","weight":0.0828},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.0931},{"period":"6month","weight":-0.0768},{"period":"1year","weight":0.0657},{"period":"ytd","weight":-0.0827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avidity Biosciences, Inc.是根据特拉华州法律于2012年11月13日成立的。该公司是一家生物制药公司。公司开创了一种新型的基于寡核苷酸的疗法,称为抗体寡核苷酸缀合物(AOC),旨在克服寡核苷酸疗法的当前局限性,以治疗多种严重的疾病。该公司利用其专有的AOC平台来设计,策划和开发结合单克隆抗体(mAbs)的组织选择性和寡核苷酸疗法的精确性的疗法,以访问以前无法吸收的组织和细胞类型,并更有效地针对疾病的潜在遗传驱动因素。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.029515},{"month":2,"riseRate":0.6,"avgChangeRate":0.100374},{"month":3,"riseRate":0.4,"avgChangeRate":-0.00029},{"month":4,"riseRate":0.2,"avgChangeRate":-0.098778},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010872},{"month":6,"riseRate":1,"avgChangeRate":0.162259},{"month":7,"riseRate":0.4,"avgChangeRate":-0.025313},{"month":8,"riseRate":0.6,"avgChangeRate":0.033831},{"month":9,"riseRate":0.4,"avgChangeRate":-0.044821},{"month":10,"riseRate":0,"avgChangeRate":-0.12124},{"month":11,"riseRate":0.6,"avgChangeRate":0.110594},{"month":12,"riseRate":0.6,"avgChangeRate":0.131559}],"exchange":"NASDAQ","name":"Avidity Biosciences, Inc.","nameEN":"Avidity Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avidity Biosciences, Inc.(RNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avidity Biosciences, Inc.(RNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avidity Biosciences, Inc.,RNA,Avidity Biosciences, Inc.股票,Avidity Biosciences, Inc.股票老虎,Avidity Biosciences, Inc.股票老虎国际,Avidity Biosciences, Inc.行情,Avidity Biosciences, Inc.股票行情,Avidity Biosciences, Inc.股价,Avidity Biosciences, Inc.股市,Avidity Biosciences, Inc.股票价格,Avidity Biosciences, Inc.股票交易,Avidity Biosciences, Inc.股票购买,Avidity Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avidity Biosciences, Inc.(RNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avidity Biosciences, Inc.(RNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}